GlaxoSmithKline (JOBS) Settles U.S. Paxil Lawsuit for $40 Million

LONDON, Oct 2 (Reuters) - GlaxoSmithKline has agreed to settle a long-standing U.S. case over its antidepressant Paxil by paying insurers $40 million to reimburse health plans that paid for children and adolescents to receive the drug.
MORE ON THIS TOPIC